Global Intradermal Needle-free Vaccination System Market Growth 2025-2031
Description
The global Intradermal Needle-free Vaccination System market size is predicted to grow from US$ 78.6 million in 2025 to US$ 124 million in 2031; it is expected to grow at a CAGR of 7.9% from 2025 to 2031.
The Intradermal Needle-free Vaccination System is a medical device designed to administer vaccines without the use of traditional needles. It uses a high-pressure jet to deliver the vaccine directly into the skin (the intradermal layer) rather than through muscle or fat. This system is typically more comfortable for patients, reduces the risk of needle-related injuries, and can improve vaccination efficiency by targeting the skin's immune cells. The needle-free technology is often used for both human and animal vaccinations, offering a less invasive and potentially more cost-effective alternative to conventional needle-based methods.
United States market for Intradermal Needle-free Vaccination System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Intradermal Needle-free Vaccination System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Intradermal Needle-free Vaccination System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Intradermal Needle-free Vaccination System players cover Henke Sass Wolf, HIPRA, Merck, Pulse NeedleFree Systems, AcuShot, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Intradermal Needle-free Vaccination System Industry Forecast” looks at past sales and reviews total world Intradermal Needle-free Vaccination System sales in 2024, providing a comprehensive analysis by region and market sector of projected Intradermal Needle-free Vaccination System sales for 2025 through 2031. With Intradermal Needle-free Vaccination System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intradermal Needle-free Vaccination System industry.
This Insight Report provides a comprehensive analysis of the global Intradermal Needle-free Vaccination System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intradermal Needle-free Vaccination System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intradermal Needle-free Vaccination System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intradermal Needle-free Vaccination System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intradermal Needle-free Vaccination System.
This report presents a comprehensive overview, market shares, and growth opportunities of Intradermal Needle-free Vaccination System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Pen-type
Gun-type
Segmentation by Application:
Pets and Small Animals
Large Animals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Henke Sass Wolf
HIPRA
Merck
Pulse NeedleFree Systems
AcuShot
NuGen Medical
Shine Moon
Jiangsu Leju Pharmaceutical Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Intradermal Needle-free Vaccination System market?
What factors are driving Intradermal Needle-free Vaccination System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intradermal Needle-free Vaccination System market opportunities vary by end market size?
How does Intradermal Needle-free Vaccination System break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The Intradermal Needle-free Vaccination System is a medical device designed to administer vaccines without the use of traditional needles. It uses a high-pressure jet to deliver the vaccine directly into the skin (the intradermal layer) rather than through muscle or fat. This system is typically more comfortable for patients, reduces the risk of needle-related injuries, and can improve vaccination efficiency by targeting the skin's immune cells. The needle-free technology is often used for both human and animal vaccinations, offering a less invasive and potentially more cost-effective alternative to conventional needle-based methods.
United States market for Intradermal Needle-free Vaccination System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Intradermal Needle-free Vaccination System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Intradermal Needle-free Vaccination System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Intradermal Needle-free Vaccination System players cover Henke Sass Wolf, HIPRA, Merck, Pulse NeedleFree Systems, AcuShot, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Intradermal Needle-free Vaccination System Industry Forecast” looks at past sales and reviews total world Intradermal Needle-free Vaccination System sales in 2024, providing a comprehensive analysis by region and market sector of projected Intradermal Needle-free Vaccination System sales for 2025 through 2031. With Intradermal Needle-free Vaccination System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intradermal Needle-free Vaccination System industry.
This Insight Report provides a comprehensive analysis of the global Intradermal Needle-free Vaccination System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intradermal Needle-free Vaccination System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intradermal Needle-free Vaccination System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intradermal Needle-free Vaccination System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intradermal Needle-free Vaccination System.
This report presents a comprehensive overview, market shares, and growth opportunities of Intradermal Needle-free Vaccination System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Pen-type
Gun-type
Segmentation by Application:
Pets and Small Animals
Large Animals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Henke Sass Wolf
HIPRA
Merck
Pulse NeedleFree Systems
AcuShot
NuGen Medical
Shine Moon
Jiangsu Leju Pharmaceutical Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Intradermal Needle-free Vaccination System market?
What factors are driving Intradermal Needle-free Vaccination System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intradermal Needle-free Vaccination System market opportunities vary by end market size?
How does Intradermal Needle-free Vaccination System break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
102 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Intradermal Needle-free Vaccination System by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Intradermal Needle-free Vaccination System by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
